Article Information
History
- July 21, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 21, 2020 - 19:13).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Min-Wen Ku1,*,
- Maryline Bourgine1,2,*,
- Pierre Authié1,*,
- Jodie Lopez1,
- Kirill Nemirov1,
- Fanny Moncoq1,
- Amandine Noirat1,
- Benjamin Vesin1,
- Fabien Nevo1,
- Catherine Blanc1,
- Philippe Souque2,
- Emeline Simon3,
- Houda Tabbal3,
- Hugo Mouquet4,
- François Anna1,
- Annette Martin3,
- Nicolas Escriou5,
- Laleh Majlessi1,£ and
- Pierre Charneau1,2,£
- 1Institut Pasteur-TheraVectys Joint Lab, 28 rue du Dr. Roux, Paris F-75015, France
- 2Molecular Virology and Vaccinology Unit, Institut Pasteur
- 3Molecular Genetics of RNA Viruses Unit, Institut Pasteur. CNRS UMR3569, Université Paris Diderot-Sorbonne, Paris Cité, Paris, France
- 4Laboratory of Humoral Immunology, Institut Pasteur, INSERM U1222
- 5Innovation Lab, Vaccines, Institut Pasteur
- ↵£Co-senior and co-corresponding authors, pierre.charneau{at}pasteur.fr
↵* Equal contribution of the authors